GB2094142B - Injectable solution containing theophylline and a basic amino acid - Google Patents

Injectable solution containing theophylline and a basic amino acid

Info

Publication number
GB2094142B
GB2094142B GB8107156A GB8107156A GB2094142B GB 2094142 B GB2094142 B GB 2094142B GB 8107156 A GB8107156 A GB 8107156A GB 8107156 A GB8107156 A GB 8107156A GB 2094142 B GB2094142 B GB 2094142B
Authority
GB
United Kingdom
Prior art keywords
amino acid
solution containing
basic amino
injectable solution
containing theophylline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8107156A
Other versions
GB2094142A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratories for Applied Biology Ltd
Original Assignee
Laboratories for Applied Biology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratories for Applied Biology Ltd filed Critical Laboratories for Applied Biology Ltd
Priority to GB8107156A priority Critical patent/GB2094142B/en
Publication of GB2094142A publication Critical patent/GB2094142A/en
Application granted granted Critical
Publication of GB2094142B publication Critical patent/GB2094142B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB8107156A 1981-03-06 1981-03-06 Injectable solution containing theophylline and a basic amino acid Expired GB2094142B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8107156A GB2094142B (en) 1981-03-06 1981-03-06 Injectable solution containing theophylline and a basic amino acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8107156A GB2094142B (en) 1981-03-06 1981-03-06 Injectable solution containing theophylline and a basic amino acid

Publications (2)

Publication Number Publication Date
GB2094142A GB2094142A (en) 1982-09-15
GB2094142B true GB2094142B (en) 1984-09-26

Family

ID=10520209

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8107156A Expired GB2094142B (en) 1981-03-06 1981-03-06 Injectable solution containing theophylline and a basic amino acid

Country Status (1)

Country Link
GB (1) GB2094142B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9050365B2 (en) 2004-04-19 2015-06-09 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US9155701B2 (en) 2009-06-24 2015-10-13 Strategic Science & Technologies, Llc Delivery of ibuprofen and other compounds
US9289495B2 (en) 2010-12-29 2016-03-22 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
US9463158B2 (en) 2009-06-24 2016-10-11 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629384B2 (en) 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US7914814B2 (en) 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
EP2417978A1 (en) * 2004-04-19 2012-02-15 Strategic Science & Technologies, LLC Beneficial effects of increasing local blood flow
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP2445493A1 (en) 2009-06-24 2012-05-02 Strategic Science & Technologies, LLC Topical composition containing naproxen

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9050365B2 (en) 2004-04-19 2015-06-09 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US9155701B2 (en) 2009-06-24 2015-10-13 Strategic Science & Technologies, Llc Delivery of ibuprofen and other compounds
US9161915B2 (en) 2009-06-24 2015-10-20 Strategic Science & Technologies, Llc Delivery of ibuprofen and other compounds
US9457092B2 (en) 2009-06-24 2016-10-04 Strategic Science & Technologies, Llc Delivery of ibuprofen and other compounds
US9463158B2 (en) 2009-06-24 2016-10-11 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US9492458B2 (en) 2009-06-24 2016-11-15 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US9289495B2 (en) 2010-12-29 2016-03-22 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
US9498482B2 (en) 2010-12-29 2016-11-22 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications

Also Published As

Publication number Publication date
GB2094142A (en) 1982-09-15

Similar Documents

Publication Publication Date Title
JPS57176941A (en) N-substituted-amide-amino acid
GR862233B (en) Insulin analogues and process for their preparation
AR244625A1 (en) Crate
GB8529058D0 (en) Amino acid ester
GB2170783B (en) Improvements in or relating to a container
GB2179641B (en) Improvements in or relating to a container
GB8519452D0 (en) Injectable solutions
GR890300071T1 (en) Improvements in or relating to hormones
GB2094142B (en) Injectable solution containing theophylline and a basic amino acid
IL65151A0 (en) Improvements in 1-benzoyl-3-(arylpyridyl)urea compounds
DE3273157D1 (en) Acid halide and acyllactam functional materials
GB8610730D0 (en) Handling structural components
EP0114695A3 (en) Dna coding for a signal amino acid sequence and dna containing the same
GB8703749D0 (en) Piperazinecarboxylic acid
GB2103232B (en) Arylazo-aminonaphtholsulfonic acid
GB2109793B (en) Phosphinylalkanoyl amino acids
GB8522404D0 (en) 6-isopropyl-2-naphthoic acid
GB8520583D0 (en) Azidosulphonylbenzoic acid
GB8624875D0 (en) 2 6-naphthalenedi-carboxylic acid
GB2098864B (en) Pharmaceutical preparation containing a guanidiine compound and a diuretic
ZA856691B (en) Amino acid derivatives
GB8405454D0 (en) Nitric acid
ZA844971B (en) 2-pentanoylaminoacetic acid and salts thereof
IL75079A0 (en) N-formyl-dithiophosphonic acid amides
GB8311621D0 (en) N-hydroxy amino acid derivatives

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19950306